Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Seguin

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Critical Care (London, England)|April 5, 2022
Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?Fabrice Thiolliere, Claire Falandry, Bernard Allaouchiche, et al.
BMJ Open|October 21, 2018
Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trialClaire Dahyot-Fizelier, Denis Frasca, Sigismond Lasocki, et al.
Annals of Intensive Care|September 2, 2022
Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patientsNicolas Massart, Florian Reizine, Pierre Fillatre, et al.
The European Respiratory Journal|January 9, 2016
Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injuryAntoine Roquilly, Fanny Feuillet, Philippe Seguin, et al.
European Journal of Anaesthesiology|February 9, 2018
Patient factors and outcomes associated with the withdrawal or withholding of life-sustaining therapies in mechanically ventilated brain-injured patients: An observational multicentre studyNicolas Nesseler, Antoine Roquilly, Sigismond Lasocki, et al.
Journal of Fungi (Basel, Switzerland)|July 16, 2020
Is the COVID-19 Pandemic a Good Time to Include <i>Aspergillus</i> Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric ExperienceJean-Pierre Gangneux, Florian Reizine, Hélène Guegan, et al.
JAMA|March 24, 2011
Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE studyAntoine Roquilly, Pierre Joachim Mahe, Philippe Seguin, et al.
Journal of Agricultural and Food Chemistry|July 12, 2008
Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from KoreaMin-Young Kim, Philippe Seguin, Joung-Kuk Ahn, et al.
Intensive Care Medicine|February 28, 2018
Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trialPhilippe Montravers, Florence Tubach, Thomas Lescot, et al.
Intensive Care Medicine|July 11, 2012
Etomidate increases susceptibility to pneumonia in trauma patientsKarim Asehnoune, Pierre Joachim Mahe, Philippe Seguin, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Critical Care (London, England)|April 5, 2022
Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: Does COVID-19 really make things worse?Fabrice Thiolliere, Claire Falandry, Bernard Allaouchiche, et al.
BMJ Open|October 21, 2018
Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trialClaire Dahyot-Fizelier, Denis Frasca, Sigismond Lasocki, et al.
Annals of Intensive Care|September 2, 2022
Multiple-site decontamination regimen decreases acquired infection incidence in mechanically ventilated COVID-19 patientsNicolas Massart, Florian Reizine, Pierre Fillatre, et al.
The European Respiratory Journal|January 9, 2016
Empiric antimicrobial therapy for ventilator-associated pneumonia after brain injuryAntoine Roquilly, Fanny Feuillet, Philippe Seguin, et al.
European Journal of Anaesthesiology|February 9, 2018
Patient factors and outcomes associated with the withdrawal or withholding of life-sustaining therapies in mechanically ventilated brain-injured patients: An observational multicentre studyNicolas Nesseler, Antoine Roquilly, Sigismond Lasocki, et al.
Journal of Fungi (Basel, Switzerland)|July 16, 2020
Is the COVID-19 Pandemic a Good Time to Include <i>Aspergillus</i> Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric ExperienceJean-Pierre Gangneux, Florian Reizine, Hélène Guegan, et al.
JAMA|March 24, 2011
Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE studyAntoine Roquilly, Pierre Joachim Mahe, Philippe Seguin, et al.
Journal of Agricultural and Food Chemistry|July 12, 2008
Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from KoreaMin-Young Kim, Philippe Seguin, Joung-Kuk Ahn, et al.
Intensive Care Medicine|February 28, 2018
Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trialPhilippe Montravers, Florence Tubach, Thomas Lescot, et al.
Intensive Care Medicine|July 11, 2012
Etomidate increases susceptibility to pneumonia in trauma patientsKarim Asehnoune, Pierre Joachim Mahe, Philippe Seguin, et al.
Pageof 13